Company Filing History:
Years Active: 2010
Title: Bentwich Itzhak: Innovator in Lung Cancer Research
Introduction
Bentwich Itzhak is a notable inventor based in Rosh-Ha′ayin, Israel. He has made significant contributions to the field of cancer research, particularly in the area of lung cancer. His work focuses on the development of innovative diagnostic and therapeutic methods.
Latest Patents
Bentwich holds a patent related to lung cancer-associated nucleic acids. This patent describes polynucleotides that are linked to lung cancer, including miRNAs, miRNA precursors, and associated nucleic acids. The patent outlines methods and compositions that can be utilized for the diagnosis, prognosis, and treatment of lung cancer. Additionally, it details techniques for identifying modulators of the disease-associated polynucleotides. The patent also includes methods for linear amplification and labeling of targeted nucleic acids, which can be applied in hybridization techniques such as Luminex and Microarray analysis.
Career Highlights
Bentwich Itzhak is affiliated with Rosetta Genomics Ltd., a company that specializes in genomic research and development. His work at Rosetta Genomics has been pivotal in advancing the understanding of lung cancer and its associated biomarkers.
Collaborations
Some of his notable coworkers include Amir Avniel and Yael Karov, who have collaborated with him on various projects related to cancer research.
Conclusion
Bentwich Itzhak's contributions to lung cancer research through his innovative patents and work at Rosetta Genomics Ltd. highlight his commitment to improving cancer diagnostics and treatment. His research continues to pave the way for advancements in the field.